Healthy Skepticism Announcements

Conference Program: Prescription for Conflict: Should Industry Fund CME? Washington DC, June 25

The conference has an outstanding line-up of speakers including:
Joshua Sharfstein, MD, Principal Deputy Commissioner, FDA,
Thomas Insel, MD, Director, National Institute of Mental Health,
Paul Thacker, an investigator for Sen. Chuck Grassley (R-Iowa),
Carl Elliott, MD, PhD, University of Minnesota,
Joel Lexchin, MD, University of Toronto,
Jeremy Greene, MD, PhD, Harvard University,
Daniel Carlat, MD, Carlat Psychiatry Report,
Edmund Pellegrino, MD, Professor Emeritus of Medicine and Medical Ethics, Georgetown University Medical Center.

The conference is a collaborative effort of GUMC’s PharmedOut with the
Kennedy Institute of Ethics and the Georgetown University Law Center,
and is open to the public.

CME and CEU credits are free with registration.

Updates and conference materials are at the conference website:
http://pharmedout.org/conference.htm
Register by Friday, June 4th; registration fees increase after that
date. Scholarships are available for students.

Flyer for posting: http://www.pharmedout.org/RxforConflictFlyer1pg.pdf
Registration information:
https://alumni.georgetown.edu/default.aspx?Page=EVNTEventDetail&EventID=1847

The agenda follows:
Prescription for Conflict: Should Industry Fund CME?
Friday, June 25, 2010
Georgetown University

8:00-8:15am
Opening Remarks
Stephen Ray Mitchell, MD, Dean for Medical Education, Georgetown
University Medical Center
Thomas Insel, MD, Director, National Institute of Mental Health,
National Institutes of Health
Anthony Scialli, MD, Clinical Professor of Obstetrics and Gynecology,
George Washington University School of Medicine

8:15-8:45am
Drug Companies and Medical Knowledge
Joel Lexchin, MD, Professor, York University and University of Toronto

8:45-10:00am
What’s Known About Industry Influence on Continuing Education of
Prescribers?
Elissa Ladd, PhD, RN, Assistant Clinical Professor, MGH Institute of
Health Professions
Daniel Carlat, MD, Associate Clinical Professor of Psychiatry, Tufts
University School of Medicine, Editor, Carlat Psychiatry Report
Adriane Fugh-Berman, MD, Associate Professor, Georgetown University
Medical Center
Jeremy Greene, MD, PhD, Assistant Professor, Harvard University

10:30-11:15am
Professionalism
Edmund Pellegrino, MD, Professor Emeritus of Medicine and Medical
Ethics, Kennedy Institute of Ethics, Georgetown University
Michael Frisch, JD, Ethics Counsel, Georgetown University Law Center

11:15am-12:00pm
Federal Views
Joshua Sharfstein, MD, Principal Deputy Commissioner, U.S. Food and Drug
Administration
Paul Thacker, Senior Investigator, Office of Senator Chuck Grassley
Julie Taitsman, JD, MD, U.S. Department of Health and Human Services
Office of Inspector General

1:15-1:45pm
Bioethicists and Pharma
Carl Elliott, MD, PhD, Professor, Center for Bioethics, University of
Minnesota School of Medicine

1:45-2:30pm
Views from Former Insiders
Mark Helm, MD, MBA, Helm Benefit Design, President
Douglas Melnick, MD, MPH, Physician, Los Angeles, CA
Glenn Demott, MS, Columbus, OH

2:45-4:00pm
Pros and Cons of Industry-Funded Education
Maureen Doyle-Scharff, MBA, FACME, Senior Director, Team Lead, Medical
Education Group, External Medical Communications
Pfizer, Inc
Norman Kahn, MD, Executive Vice-President and CEO, Council of Medical
Specialty Societies
David Davis, MD, Senior Director, Continuing Education and Performance
Improvement, Association of American Medical Colleges
Mike Saxton, MEd, Consultant
Douglas Melnick, MD, MPH, Physician, Los Angeles, CA
Moderator: Alicia Mundy, Wall Street Journal

4:00-4:45pm
Is Industry-free CME a Sustainable Model?
Robert Wittes, MD, Physician-in-Chief, Memorial Sloan-Kettering Cancer
Center
Steve Willis, MD, Professor, East Carolina University, Executive
Director, Eastern Area Health Education Center
Hanadi Shamkhani, MD, RPh, Kaiser-Permanente

4:45-5:30pm
Next Steps—Discussion

Announcements homepage

Page views since 15 March 2010: 3443